International Review of Ophthalmology

Previous Articles     Next Articles

The current research status of the corneal neovascularization treatment

WEN Shu, YANG Wei   

  1. Department of Ophthalmology, First Hospital Affiliated to Shihezi University, Shihezi Xinjiang Uygur Autonomous Region 832000, China
  • Received:2016-09-30 Online:2017-02-22 Published:2017-02-20
  • Contact: YANG Wei, Email: yangwei1959@126.com

Abstract:

Corneal neovascularization(CNV) is one of the important pathological changes that leads to serious vision decline or even blindness. In recent years, with the deep study of molecular biology, immunology and pharmacology, the methods of treating CNV have made a breakthrough. At present, the common treatment methods include hormone drugs, anti-vascular endothelial growth factor, conjunctival transplantation, photodynamic therapy and so on. However, there is no effective therapeutic medicine or cure methods for CNV. How to prevent and treat CNV has become a hotspot in research in ophthalmology.  (Int Rev Ophthalmol,  2017,  41:   43-47)